NeuroMetrix, Inc. Stock price

Equities

NURO

US6412558800

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
4.25 USD +2.16% Intraday chart for NeuroMetrix, Inc. +4.42% +18.06%
Sales 2022 8.26M Sales 2023 5.9M Capitalization 3.87M
Net income 2022 -4M Net income 2023 -6M EV / Sales 2022 -1.12 x
Net cash position 2022 20.84M Net cash position 2023 17.76M EV / Sales 2023 -2.35 x
P/E ratio 2022
-2.41 x
P/E ratio 2023
-0.57 x
Employees 26
Yield 2022 *
-
Yield 2023
-
Free-Float 84.06%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.16%
1 week+4.42%
Current month+4.68%
1 month-0.47%
3 months+12.43%
6 months-19.63%
Current year+18.06%
More quotes
1 week
4.00
Extreme 4
4.28
1 month
3.58
Extreme 3.5816
4.28
Current year
2.70
Extreme 2.7
4.42
1 year
2.70
Extreme 2.7
12.04
3 years
2.70
Extreme 2.7
310.00
5 years
2.70
Extreme 2.7
310.00
10 years
2.70
Extreme 2.7
8 064.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 96-05-31
Director of Finance/CFO 72 09-09-09
Corporate Officer/Principal - 22-01-09
Members of the board TitleAgeSince
Director/Board Member 65 10-12-16
Director/Board Member 67 04-05-31
Chief Executive Officer 59 96-05-31
More insiders
Date Price Change Volume
24-03-28 4.25 +2.16% 9,178
24-03-27 4.16 +4.00% 2,753
24-03-26 4 -1.96% 6,415
24-03-25 4.08 -1.69% 16,159
24-03-22 4.15 +1.97% 15,572

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. It operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.
More about the company
  1. Stock
  2. Equities
  3. Stock NeuroMetrix, Inc. - Nasdaq